EphA4 signaling is involved in the phenotype of well-differentiated oral squamous cell arcinoma with decreased tumor immunity

Metronomic chemotherapy is defined as a high-frequency low-dose schedule of chemotherapy drug administration. Although metronomic chemotherapy is widely used, the mechanisms underlying resistance to metronomic chemotherapy remain unclear. Therefore, we herein conducted a single institutional phase I...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of pharmacology 2023-04, Vol.945, p.175611-175611, Article 175611
Hauptverfasser:	Kina, Shinichiro, Kawabata-Iwakawa, Reika, Miyamoto, Sho, Kato, Tomoki, Kina-Tanada, Mika, Arasaki, Akira
Format:	Artikel
Sprache:	eng
Schlagworte:	Carcinoma, Squamous Cell - drug therapy Carcinoma, Squamous Cell - metabolism Epithelial Cells - metabolism Head and Neck Neoplasms - drug therapy Humans Mouth Neoplasms - metabolism Phenotype Receptor, EphA4 - metabolism Squamous Cell Carcinoma of Head and Neck - drug therapy Tumor Microenvironment
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!